OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
Juan Li, Shi Liwei, Ke Li, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7212-7219
Open Access | Times Cited: 8
Juan Li, Shi Liwei, Ke Li, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7212-7219
Open Access | Times Cited: 8
Showing 8 citing articles:
Current status and future directions for the development of human papillomavirus vaccines
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
Emilia Włoszek, Katherine Krupa, Eliza Skrok, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 122-122
Open Access
Emilia Włoszek, Katherine Krupa, Eliza Skrok, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 122-122
Open Access
Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults
Donald J. Alcendor, Patricia Matthews-Juarez, Mohammad Tabatabai, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 311-311
Open Access
Donald J. Alcendor, Patricia Matthews-Juarez, Mohammad Tabatabai, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 311-311
Open Access
Development of a Chemiluminescence Enzyme Immunoassay (Cleia) for Quantitating L1 Protein in Hpv Vaccines
Chengrui Fei, Huan Yang, S. Wang, et al.
(2025)
Closed Access
Chengrui Fei, Huan Yang, S. Wang, et al.
(2025)
Closed Access
HPV Vaccine Uptake in Tennessee: Implications for Improving HPV Vaccine Coverage with the Inclusion of Mid-adults
Donald J. Alcendor, Mohammad Tabatabai, Patricia Juárez, et al.
(2024)
Open Access | Times Cited: 1
Donald J. Alcendor, Mohammad Tabatabai, Patricia Juárez, et al.
(2024)
Open Access | Times Cited: 1
Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine Candidate in Mice
Lei Bei, Shuman Gao, Dandan Zhao, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1262-1262
Open Access
Lei Bei, Shuman Gao, Dandan Zhao, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1262-1262
Open Access
A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
Dan Xu, Jiadai Li, Jiao An, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1356-1356
Open Access
Dan Xu, Jiadai Li, Jiao An, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1356-1356
Open Access
